# Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients

> **NCT02156479** · — · COMPLETED · sponsor: **Lophius Biosciences GmbH** · enrollment: 175 (actual)

## Conditions studied

- Cytomegalovirus Infection
- GVHD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02156479
- **Lead sponsor:** Lophius Biosciences GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2018-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02156479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02156479, "Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02156479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*